PCM
WVE icon

Prelude Capital Management’s Wave Life Sciences WVE Stock Holding History

Prelude Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-93,202
Closed -$1.58M – 1636
2025
Q4 		$1.58M Buy
+93,202
New +$947K 0.12% 192
2025
Q2 		– Sell
-109,330
Closed -$883K – 1423
2025
Q1 		$883K Buy
+109,330
New +$1.2M 0.09% 341
2024
Q3 		– Sell
-135,200
Closed -$675K – 1603
2024
Q2 		$675K Sell
135,200
-9,100
-6% -$51.9K 0.06% 418
2024
Q1 		$890K Buy
+144,300
New +$723K 0.06% 427
2021
Q4 		– Sell
-13,893
Closed -$68K – 2442
2021
Q3 		$68K Buy
+13,893
New +$84.2K ﹤0.01% 1534
2021
Q1 		– Sell
-27,294
Closed -$215K – 2020
2020
Q4 		$215K Buy
+27,294
New +$229K 0.02% 1083

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return